Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
October 2, 2025
Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based study
Ali Inan El-Naggar, Andreas Karakatsanis, Antonios Valachis
Advances in Database Technology : Proceedings. International Conference on Extending Database Technology
|
February 7, 2014
Efficient Privacy-Aware Record Integration
Mehmet Kuzu, Murat Kantarcioglu, Ali Inan, et al.
JCO Oncology Practice
|
February 9, 2026
Influenza Vaccination Among Patients With Cancer Treated With Checkpoint Inhibitors: Association With Survival Outcomes and Immune-Related Adverse Events
Anthoula Koliadi, Evangelos Digkas, Ali Inan El-Naggar, et al.
Pigment Cell & Melanoma Research
|
December 29, 2023
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis
Viktoria Rydén, Ali Inan El-Naggar, Anthoula Koliadi, et al.
Cancer Medicine
|
May 3, 2023
Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, et al.
Frontiers in Oncology
|
July 11, 2024
Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, et al.
Environmental Science and Pollution Research International
|
September 23, 2025
Ranking circularity levels in industrial parks: a holistic approach incorporating environmental, economic and social indicators
Istemi Berk, Volkan Ş Ediger, Engin Bağış Öztürk, et al.
Cancer Immunology, Immunotherapy : CII
|
November 7, 2024
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
Cecilia Olsson Ladjevardi, Marcus Skribek, Anthoula Koliadi, et al.
Journal of the National Cancer Institute
|
January 22, 2025
Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementation
Ioannis Zerdes, Panagiotis Filis, Georgios Fountoukidis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Acta Oncologica (Stockholm, Sweden)
|
October 2, 2025
Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based study
Ali Inan El-Naggar, Andreas Karakatsanis, Antonios Valachis
Advances in Database Technology : Proceedings. International Conference on Extending Database Technology
|
February 7, 2014
Efficient Privacy-Aware Record Integration
Mehmet Kuzu, Murat Kantarcioglu, Ali Inan, et al.
JCO Oncology Practice
|
February 9, 2026
Influenza Vaccination Among Patients With Cancer Treated With Checkpoint Inhibitors: Association With Survival Outcomes and Immune-Related Adverse Events
Anthoula Koliadi, Evangelos Digkas, Ali Inan El-Naggar, et al.
Pigment Cell & Melanoma Research
|
December 29, 2023
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis
Viktoria Rydén, Ali Inan El-Naggar, Anthoula Koliadi, et al.
Cancer Medicine
|
May 3, 2023
Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, et al.
Frontiers in Oncology
|
July 11, 2024
Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, et al.
Environmental Science and Pollution Research International
|
September 23, 2025
Ranking circularity levels in industrial parks: a holistic approach incorporating environmental, economic and social indicators
Istemi Berk, Volkan Ş Ediger, Engin Bağış Öztürk, et al.
Cancer Immunology, Immunotherapy : CII
|
November 7, 2024
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
Cecilia Olsson Ladjevardi, Marcus Skribek, Anthoula Koliadi, et al.
Journal of the National Cancer Institute
|
January 22, 2025
Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementation
Ioannis Zerdes, Panagiotis Filis, Georgios Fountoukidis, et al.
Page
of 1